RobertVan BurenEmmonsMD

Hematology • Louisville, KY

Hematologic Oncology

University of Louisville

Join to view full profile

Dr. Emmons is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Emmons' full profile

Already have an account?

Office
529 S Jackson St
Rm. 423
Louisville, KY 40202
Phone+1 502-562-4569

Fax+1 502-561-8694

Summary

Dr. Robert Emmons is a hematologist in Louisville, KY. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 28 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hematopoietic stem cell transplantation.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1992 - 1994
University of MichiganResidency, Internal Medicine, 1989 - 1992
University of Cincinnati College of MedicineClass of 1989

Certifications & Licensure

KY State Medical License 2017 - 2026
LA State Medical License 2012 - 2020
PA State Medical License 2003 - 2012
MD State Medical License 1993 - 1998

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701) Start of enrollment: 2009 Apr 01
Completed
Phase 2
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Start of enrollment: 2013 Aug 27
ACTIVE_NOT_RECRUITING
PHASE2
Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2014 Jan 15
ACTIVE_NOT_RECRUITING
PHASE3
Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma Start of enrollment: 2013 Dec 01
Terminated
Phase 2
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Start of enrollment: 2014 May 19
ACTIVE_NOT_RECRUITING
PHASE3
Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Start of enrollment: 2014 Mar 10
ACTIVE_NOT_RECRUITING
PHASE3
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Feb 04
COMPLETED
PHASE3
Join now to see all

Publications & Presentations

PubMed

1 citations
Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis
Hamza Hashmi, Shruti Bhandari, Rohit Kumar, Prashant Tripathi, Jill Rhodes
Hematology/oncology and Stem Cell Therapy. 2020-12-01
147 citations
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma.
Sagar Lonial, Susanna Jacobus, Rafael Fonseca, Matthias Weiss, Shaji Kumar
Journal of Clinical Oncology. 2020-04-10
1 citations
Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft-versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplant: A Single Institu...
Hamza Hashmi, Shruti Bhandari, Jugraj Dhanoa, Xiaoyong Wu, Shesh N. Rai
Cureus. 2020-02-05

Press Mentions

Liz Weston: How Gratitude Can Help Your Financial LifeOctober 4th, 2021
Does Practicing Gratitude Help Your Immune System?August 9th, 2021
If You Truly Value Your Time, Practice PatienceJuly 26th, 2021
Join now to see all